David McCarey

4.1k total citations · 3 hit papers
14 papers, 3.1k citations indexed

About

David McCarey is a scholar working on Rheumatology, Surgery and Immunology. According to data from OpenAlex, David McCarey has authored 14 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 5 papers in Surgery and 4 papers in Immunology. Recurrent topics in David McCarey's work include Rheumatoid Arthritis Research and Therapies (11 papers), Systemic Lupus Erythematosus Research (8 papers) and Lipoproteins and Cardiovascular Health (5 papers). David McCarey is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (11 papers), Systemic Lupus Erythematosus Research (8 papers) and Lipoproteins and Cardiovascular Health (5 papers). David McCarey collaborates with scholars based in United Kingdom, Belgium and Greece. David McCarey's co-authors include Iain B. McInnes, Naveed Sattar, Hilary A. Capell, Rajan Madhok, Olga Scherbakova, Ian Ford, Gayle McKellar, Tore K Kvien, Zoltán Szekanecz and B. A. C. Dijkmans and has published in prestigious journals such as The Lancet, Circulation and The Journal of Immunology.

In The Last Decade

David McCarey

14 papers receiving 3.0k citations

Hit Papers

EULAR evidence-based recommendations for cardiovascular r... 2003 2026 2010 2018 2009 2003 2004 250 500 750

Peers

David McCarey
Annette Oeser United States
Maureen McMahon United States
Young Hee Rho South Korea
Hilary A. Capell United Kingdom
Paul R. J. Ames United Kingdom
Arthur L. Weaver United States
Annette Oeser United States
David McCarey
Citations per year, relative to David McCarey David McCarey (= 1×) peers Annette Oeser

Countries citing papers authored by David McCarey

Since Specialization
Citations

This map shows the geographic impact of David McCarey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David McCarey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David McCarey more than expected).

Fields of papers citing papers by David McCarey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David McCarey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David McCarey. The network helps show where David McCarey may publish in the future.

Co-authorship network of co-authors of David McCarey

This figure shows the co-authorship network connecting the top 25 collaborators of David McCarey. A scholar is included among the top collaborators of David McCarey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David McCarey. David McCarey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Robertson, Jamie, Duncan Porter, Naveed Sattar, et al.. (2017). Interleukin-6 blockade raises LDL via reduced catabolism rather than via increased synthesis: a cytokine-specific mechanism for cholesterol changes in rheumatoid arthritis. Annals of the Rheumatic Diseases. 76(11). 1949–1952. 70 indexed citations
3.
Baxter, Derek, et al.. (2013). AB0218 Addressing cardiovascular risk in treatment resistant ra. Annals of the Rheumatic Diseases. 72. A853–A853. 1 indexed citations
4.
McCarey, David & R D Sturrock. (2010). Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis.. PubMed. 27(4 Suppl 55). S124–6. 24 indexed citations
5.
McKellar, Gayle, David McCarey, Naveed Sattar, & Iain B. McInnes. (2009). Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nature Reviews Cardiology. 6(6). 410–417. 231 indexed citations
6.
Peters, M.J., Deborah Symmons, David McCarey, et al.. (2009). EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Annals of the Rheumatic Diseases. 69(2). 325–331. 969 indexed citations breakdown →
7.
McCarey, David & Iain B. McInnes. (2007). Psoriatic arthritis: Current topics. Current Rheumatology Reports. 9(6). 442–448. 10 indexed citations
8.
McCarey, David, Naveed Sattar, & Iain B. McInnes. (2005). Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases?. Arthritis Research. 7(2). 55–55. 27 indexed citations
9.
McCarey, David, Iain B. McInnes, Rajan Madhok, et al.. (2004). Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. The Lancet. 363(9426). 2015–2021. 612 indexed citations breakdown →
10.
McCarey, David, Iain B. McInnes, & Rajan Madhok. (2004). Trial of atorvastatin in rheumatoid arthritis (TARA): Double-blind, randomised placebo-controlled trial. ACC Current Journal Review. 13(9). 11–12. 9 indexed citations
11.
McInnes, Iain B., Naveed Sattar, David McCarey, Rajan Madhok, & H A Capell. (2004). Statins and rheumatoid arthritis. The Lancet. 364(9448). 1855–1855. 1 indexed citations
12.
Leung, Bernard P., Naveed Sattar, Anne Crilly, et al.. (2003). A Novel Anti-Inflammatory Role for Simvastatin in Inflammatory Arthritis. The Journal of Immunology. 170(3). 1524–1530. 361 indexed citations
13.
Sattar, Naveed, David McCarey, Hilary A. Capell, & Iain B. McInnes. (2003). Explaining How “High-Grade” Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis. Circulation. 108(24). 2957–2963. 707 indexed citations breakdown →
14.
Capell, Hilary A., et al.. (2002). "5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy.. PubMed. 29(10). 2099–105. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026